CIT can broadcast your seminar, conference or meeting live to a world-wide audience over the Internet
as a real-time streaming video. The event can be recorded and made available for viewers to watch at
their convenience as an on-demand video or a downloadable file. CIT can also broadcast NIH-only or HHS-only content.
AED Monotherapy Workshop Day 1
Thursday, March 8, 2001,
8:00:00 AM Time displayed is Eastern Time, Washington DC Local
Total views: 89 * This only includes stats from October 2011 and forward.
Over the past decade there have been 8 new drugs approved for the treatment of epilepsy. Most of these have been approved initially as adjunctive therapy in highly refractory patients with partial seizures. Only two (felbamate and oxcarbazebine) received an indication for use as monotherapy at the time of approval. Subsequently, a third (lamotrigine) has received an indication for withdrawal to monotherapy in refractory patients.
The use of antiepileptic drugs in monotherapy is supported by data from numerous clinical studies. Refractory patients treated with two or more drugs have better seizure control and fewer side effects when converted to monotherapy. Conversely, when newly diagnosed or refractory patients go from monotherapy to polytherapy, only a small percentage have a substantial reduction in seizures, and most have an increase in side effects.
AED monotherapy workshop.
National Institutes of Health (U.S.)
Anticonvulsants--therapeutic use Clinical Trials as Topic Drug Approval Epilepsy--drug therapy
This is a work of the United States Government. No copyright exists on this material. It may be disseminated freely.